Ann and Robert H. Lurie Children's Hospital: CRISPR-Cas9 Gene Editing Shows Very Low Risk of Mistakes
December 03, 2019
December 03, 2019
CHICAGO, Illinois, Dec. 3 -- The Ann and Robert H. Lurie Children's Hospital issued the following news release:
* * *
- Zebrafish study further supports accuracy of CRISPR-Cas9 gene editing tool, provides reassurance for use in human treatments
* * *
Along with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gen . . .
* * *
- Zebrafish study further supports accuracy of CRISPR-Cas9 gene editing tool, provides reassurance for use in human treatments
* * *
Along with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gen . . .